Globus Medical, Inc.
GMED
$58.17
-$0.08-0.14%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 32.26% | 60.62% | 102.10% | 103.89% | 77.59% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 32.26% | 60.62% | 102.10% | 103.89% | 77.59% |
| Cost of Revenue | 35.10% | 65.47% | 131.21% | 161.99% | 122.44% |
| Gross Profit | 30.90% | 58.39% | 90.32% | 83.65% | 62.03% |
| SG&A Expenses | 26.64% | 52.41% | 88.08% | 90.02% | 69.61% |
| Depreciation & Amortization | 55.70% | 133.92% | 328.90% | 463.29% | 326.99% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 27.26% | 58.53% | 111.22% | 124.69% | 96.50% |
| Operating Income | 61.16% | 71.44% | 64.16% | 32.61% | 14.10% |
| Income Before Tax | 148.76% | -27.01% | -40.23% | -74.54% | -63.61% |
| Income Tax Expenses | 75.38% | -58.28% | -33.79% | -54.69% | -51.84% |
| Earnings from Continuing Operations | 178.51% | -16.19% | -42.05% | -80.09% | -66.89% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 178.51% | -16.19% | -42.05% | -80.09% | -66.89% |
| EBIT | 61.16% | 71.44% | 64.16% | 32.61% | 14.10% |
| EBITDA | 55.00% | 72.95% | 97.24% | 74.63% | 46.72% |
| EPS Basic | 112.87% | -35.88% | -57.22% | -85.30% | -68.13% |
| Normalized Basic EPS | 31.47% | 12.84% | 12.71% | -9.61% | -9.90% |
| EPS Diluted | 112.66% | -35.72% | -57.31% | -85.57% | -68.02% |
| Normalized Diluted EPS | 30.33% | 12.80% | 13.45% | -8.83% | -8.93% |
| Average Basic Shares Outstanding | 11.73% | 20.09% | 31.36% | 30.40% | 21.61% |
| Average Diluted Shares Outstanding | 12.84% | 20.05% | 30.37% | 29.19% | 20.23% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |